Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1/2 1

Status

Unknown 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Prostatic Neoplasms 6Thyroid Nodule 5Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 3Thyroid Cancer, Papillary 3Uterine Cervical Dysplasia 2Sarcoma 2Prostatic Hyperplasia 2Papillomavirus Infections 2Melanoma 2Liver Neoplasms 2Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Urinary Bladder, Neurogenic 1Urinary Bladder Neoplasms 1Spinal Dysraphism 1Spinal Cord Compression 1Recurrence 1Precancerous Conditions 1Papillary Thyroid Microcarcinoma 1Pancreatic Ductal Adenocarcinoma 1Neoplasms, Unknown Primary 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Hypospadias 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Transurethral Resection of Prostate × Clear all
NCT06609876 2024-12-03

Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC

Sun Yat-sen University

Phase NA Recruiting
108 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT03864211 2022-09-29

Thermal Ablation Followed by Immunotherapy for HCC

Xiangya Hospital of Central South University

Phase 1/2 Unknown
145 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05240404 2022-02-15

Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma

Xiangya Hospital of Central South University

Phase 2 Unknown
116 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02630108 2016-10-18

TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma

Shanghai Zhongshan Hospital

Phase 3 Unknown
280 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡